Literature DB >> 2892078

Transient leucopenia induced by granulocyte-macrophage colony-stimulating factor.

S Devereux, D C Linch, D Campos Costa, M F Spittle, A M Jelliffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2892078     DOI： 10.1016/s0140-6736(87)92654-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Haematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man.

Authors:  M J Peters; A B Breslin; A S Kemp; J Chu; N Berend
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 2.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer.

Authors:  Douglas G McNeel; Jens C Eickhoff; Laura E Johnson; Alison R Roth; Timothy G Perk; Lawrence Fong; Emmanuel S Antonarakis; Ellen Wargowski; Robert Jeraj; Glenn Liu
Journal:  J Clin Oncol       Date:  2019-10-23       Impact factor: 44.544

4.  GM-CSF differentially regulates eosinophil and neutrophil adhesive interactions with vascular endothelium in vivo.

Authors:  Nooshin Sheikh Bahaie; Savita P Rao; Ahmad Massoud; P Sriramarao
Journal:  Iran J Allergy Asthma Immunol       Date:  2010-12       Impact factor: 1.464

5.  Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo.

Authors:  I E Addison; B Johnson; S Devereux; A H Goldstone; D C Linch
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

6.  Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor (rhG-CSF) to the rabbit.

Authors:  R W Niven; F D Lott; A Y Ip; J M Cribbs
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

7.  The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

Authors:  B I Lord; M H Bronchud; S Owens; J Chang; A Howell; L Souza; T M Dexter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Clinical significance of the haemopoietic growth factors.

Authors:  S Devereux; D C Linch
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

9.  A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancer.

Authors:  S Kehoe; C J Poole; A Stanley; H M Earl; G R Blackledge
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

10.  Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.

Authors:  W P Steward; J H Scarffe; R Austin; E Bonnem; N Thatcher; G Morgenstern; D Crowther
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.